Published in Am J Transplant on February 28, 2007
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Cumulative incidence of cancer after solid organ transplantation. Cancer (2013) 1.58
Chronic kidney disease and cancer: a troubling connection. J Nephrol (2010) 1.18
Incidence and risk factors for hepatocellular carcinoma after solid organ transplantation. Transplantation (2008) 1.13
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun (2008) 1.09
Cancer in the transplant recipient. Cold Spring Harb Perspect Med (2013) 1.06
Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiol Biomarkers Prev (2010) 1.03
Renal cell cancer among African Americans: an epidemiologic review. BMC Cancer (2011) 1.01
Systematic review of melanoma incidence and prognosis in solid organ transplant recipients. Transplant Res (2014) 0.96
Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update. J Cancer Epidemiol (2012) 0.95
Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers? J Natl Cancer Inst (2009) 0.94
Plasma cell neoplasms in US solid organ transplant recipients. Am J Transplant (2013) 0.92
Time to consider HPV vaccination after allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2010) 0.90
Risk of bladder cancer in renal transplant recipients: a meta-analysis. Br J Cancer (2014) 0.90
Long-term follow-up of kidney transplant recipients: comparison of hospitalization rates to the general population. Transplant Res (2013) 0.90
Risk of hepatobiliary cancer after solid organ transplant in the United States. Clin Gastroenterol Hepatol (2013) 0.81
Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol (2014) 0.80
Validation of kidney transplantation using administrative data. Can J Kidney Health Dis (2015) 0.80
Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic). Ther Adv Hematol (2016) 0.79
Clinical characteristics and treatment outcomes of colorectal cancer in renal transplant recipients in Korea. Yonsei Med J (2011) 0.79
Risk of Colorectal Cancer After Solid Organ Transplantation in the United States. Am J Transplant (2016) 0.79
Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database. PLoS One (2016) 0.78
A retrospective review of patients with urothelial cancer in 3,370 recipients after renal transplantation: a single-center experience. World J Urol (2014) 0.78
Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients. World J Surg Oncol (2011) 0.78
Malignancies after pediatric kidney transplantation: more than PTLD? Pediatr Nephrol (2013) 0.78
Cancer incidence in kidney transplant recipients: a study protocol. BMC Cancer (2009) 0.78
Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis--an observational cohort study. BMC Nephrol (2013) 0.77
Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan. PLoS One (2016) 0.75
Novel Immunotherapies for Autoimmune Hepatitis. Front Pediatr (2017) 0.75
De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study. Oncotarget (2016) 0.75
Memory CD4(+) T cells are suppressed by CD8(+) regulatory T cells in vitro and in vivo. Am J Transl Res (2017) 0.75
Comparison of hematological alterations and markers of B-cell activation in workers exposed to benzene, formaldehyde and trichloroethylene. Carcinogenesis (2016) 0.75
Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients. Lupus Sci Med (2016) 0.75
Clinical and Economic Consequences of Early Cancer after Kidney Transplantation in Contemporary Practice. Transplantation (2016) 0.75
Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies. Mol Clin Oncol (2016) 0.75
Malignancies in a renal transplant population: The St. Michael's Hospital experience. Urol Ann (2016) 0.75
Oncological, functional and perioperative outcomes in transplant patients after radical prostatectomy. World J Urol (2016) 0.75
The correlation between renal transplantation and liver carcinoma: a meta-analysis. Oncotarget (2017) 0.75
Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53
A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature (2001) 6.78
A cortical area selective for visual processing of the human body. Science (2001) 5.92
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Contextual cueing: implicit learning and memory of visual context guides spatial attention. Cogn Psychol (1998) 5.17
Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A (1998) 5.15
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res (1998) 4.68
Activation of the transcription factor MEF2C by the MAP kinase p38 in inflammation. Nature (1997) 4.59
Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res (2000) 3.83
Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J Biol Chem (1996) 3.63
TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J (1998) 3.49
Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer. J Clin Oncol (1999) 3.48
Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum (1998) 2.91
Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J Biol Chem (1999) 2.86
Validity of sexual histories in a prospective study of male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol (1988) 2.81
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80
Acute renal failure in case of Paraquat poisoning. Br Med J (1968) 2.74
Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 2.74
Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol (2001) 2.73
Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kidney Dis (1997) 2.63
Serum antibodies in epilepsy and seizure-associated disorders. Neurology (2005) 2.53
Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst (1997) 2.52
PRAK, a novel protein kinase regulated by the p38 MAP kinase. EMBO J (1998) 2.44
Calculating life years from transplant (LYFT): methods for kidney and kidney-pancreas candidates. Am J Transplant (2008) 2.39
Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer (2001) 2.36
Ypt1p implicated in v-SNARE activation. Nature (1994) 2.29
End-stage renal disease in Canada: prevalence projections to 2005. CMAJ (1999) 2.25
Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron (1999) 2.25
Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant (2006) 2.14
Farming and prostate cancer mortality. Am J Epidemiol (1993) 2.10
Economic burden of smoking in China, 2000. Tob Control (2006) 2.08
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med (2000) 2.07
Risk factors for HIV infection in male sexual contacts of men with AIDS or an AIDS-related condition. Am J Epidemiol (1988) 2.05
Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b. Immunity (1997) 2.04
Mechanism of action of camptothecin. Ann N Y Acad Sci (2000) 2.01
Mortality study of Canadian male farm operators: non-Hodgkin's lymphoma mortality and agricultural practices in Saskatchewan. J Natl Cancer Inst (1990) 2.00
The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun (1996) 1.99
Attributable causes of cancer in China. Ann Oncol (2012) 1.98
Transcriptional adaptor and histone acetyltransferase proteins in Arabidopsis and their interactions with CBF1, a transcriptional activator involved in cold-regulated gene expression. Nucleic Acids Res (2001) 1.96
Mortality after kidney transplantation: a comparison between the United States and Canada. Am J Transplant (2006) 1.92
Prostate cancer trends in Canada: rising incidence or increased detection? CMAJ (1993) 1.91
Editors and editing of anti-DNA receptors. Immunity (2001) 1.90
Genetic dissection of autoimmune type I diabetes in the BB rat. Nat Genet (1992) 1.87
Order of intron removal during splicing of endogenous adenine phosphoribosyltransferase and dihydrofolate reductase pre-mRNA. Mol Cell Biol (1993) 1.85
Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med (2001) 1.78
Second primary malignancies following diagnosis of small-cell lung cancer. J Clin Oncol (1992) 1.77
Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol (2000) 1.73
Trends in childhood injury mortality in Canada, 1979-2002. Inj Prev (2006) 1.73
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors. Ann Oncol (2009) 1.68
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia (2010) 1.68
The spectrum of bone disease in end-stage renal failure--an evolving disorder. Kidney Int (1993) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology (2004) 1.65
The Schizosaccharomyces pombe origin recognition complex interacts with multiple AT-rich regions of the replication origin DNA by means of the AT-hook domains of the spOrc4 protein. Proc Natl Acad Sci U S A (2001) 1.64
Characterization of newly emerging Newcastle disease virus isolates from the People's Republic of China and Taiwan. J Clin Microbiol (2001) 1.63
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut (2005) 1.63
Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group. J Clin Oncol (1999) 1.63
The biocontrol strain Pseudomonas fluorescens F113 produces the Rhizobium small bacteriocin, N-(3-hydroxy-7-cis-tetradecenoyl)homoserine lactone, via HdtS, a putative novel N-acylhomoserine lactone synthase. Microbiology (2000) 1.63
DNA polymerase epsilon may be dispensable for SV40- but not cellular-DNA replication. EMBO J (1996) 1.62
Serum iron and risk of fatal acute myocardial infarction. Epidemiology (1994) 1.61
Passive and active smoking and breast cancer risk in Canada, 1994-97. Cancer Causes Control (2000) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
The reliability of sexual histories in AIDS-related research: evaluation of an interview-administered questionnaire. Can J Public Health (1987) 1.60
Photoconductive characteristics of single-crystal CdS nanoribbons. Nano Lett (2006) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
[Correlation between gene expression of CCK-A receptor and gallbladder emptying in gallstone patients]. Zhonghua Wai Ke Za Zhi (1999) 1.56
Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals. HIV Med (2013) 1.56
Comparing mortality rates on CAPD/CCPD and hemodialysis. The Canadian experience: fact or fiction? Perit Dial Int (1999) 1.55
Fatal accidental childhood injuries in Canada. Can J Public Health (1987) 1.52
Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol (1984) 1.51
Repeat organ transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.50
Cervical cancer screening: are the 1989 recommendations still valid? National Workshop on Screening for Cancer of the Cervix. CMAJ (1996) 1.49
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene (2007) 1.45
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br J Cancer (2006) 1.44
Sex inequality in kidney transplantation rates. Arch Intern Med (2000) 1.43
Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy (2008) 1.43
Premature deaths in Canada: impact, trends and opportunities for prevention. Can J Public Health (1991) 1.42
Mortality on Canadian Indian Reserves 1977-1982. Can J Public Health (1986) 1.42
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol (1989) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat Med (2000) 1.41
Lymphoma of the gastrointestinal tract. Semin Oncol (1999) 1.41
Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene (2006) 1.40
Sexual behaviour changes in a cohort of male sexual contacts of men with HIV disease: a three-year overview. Can J Public Health (1991) 1.40
Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol (2008) 1.39
Bet1p activates the v-SNARE Bos1p. Mol Biol Cell (1997) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med (1987) 1.38
Parkinson's disease-associated alpha-synuclein is more fibrillogenic than beta- and gamma-synuclein and cannot cross-seed its homologs. J Biol Chem (2000) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Tumor necrosis factor modulates fibroblast apoptosis, PMN recruitment, and osteoclast formation in response to P. gingivalis infection. J Dent Res (2001) 1.34
Risk factors for prostate cancer: results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group. Cancer Causes Control (1999) 1.32
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study. Eur J Cancer (1996) 1.32
Activating mutations of the calcium-sensing receptor: management of hypocalcemia. J Clin Endocrinol Metab (2001) 1.31
An evaluation on smoking-induced health costs in China (1988-1989). Biomed Environ Sci (1995) 1.30
VP-16 and cisplatin as first-line therapy for small-cell lung cancer. J Clin Oncol (1985) 1.30
Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation. Biochemistry (2001) 1.29
Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis. Kidney Int (2001) 1.28